(TJX) The TJX Companies - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8725401090
Stock:
Total Rating 74
Risk 73
Buy Signal 0.54
| Risk 5d forecast | |
|---|---|
| Volatility | 16.9% |
| Relative Tail Risk | -1.98% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.40 |
| Alpha | 21.32 |
| Character TTM | |
|---|---|
| Beta | 0.443 |
| Beta Downside | -0.047 |
| Drawdowns 3y | |
|---|---|
| Max DD | 11.04% |
| CAGR/Max DD | 2.68 |
EPS (Earnings per Share)
Revenue
Description: TJX The TJX Companies
The TJX Companies, Inc., together with its subsidiaries, operates as an off-price apparel and home fashions retailer worldwide. The company operates through four segments: Marmaxx, HomeGoods, TJX Canada, and TJX International. It offers family apparel comprising footwear; accessories, such as beauty and jewelry; home fashion products, including home basics, decorative accessories and giftware, as well as furniture, rugs, lighting, soft home, decorative accessories, tabletop, and cookware; pet and gourmet food; and other merchandise. The company also provides home decor, furniture, and seasonal home merchandise. It sells its products through stores and e-commerce sites. The TJX Companies, Inc. was incorporated in 1962 and is headquartered in Framingham, Massachusetts.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 5.49b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 0.35 > 1.0 |
| NWC/Revenue: 3.05% < 20% (prev 3.52%; Δ -0.47% < -1%) |
| CFO/TA 0.19 > 3% & CFO 6.81b > Net Income 5.49b |
| Net Debt (16.15b) to EBITDA (8.28b): 1.95 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.12b) vs 12m ago -1.14% < -2% |
| Gross Margin: 31.06% > 18% (prev 0.31%; Δ 3075 % > 0.5%) |
| Asset Turnover: 178.8% > 50% (prev 177.5%; Δ 1.32% > 0%) |
| Interest Coverage Ratio: 54.65 > 6 (EBITDA TTM 8.28b / Interest Expense TTM 91.0m) |
Altman Z'' 2.54
| A: 0.05 (Total Current Assets 15.20b - Total Current Liabilities 13.36b) / Total Assets 35.77b |
| B: 0.24 (Retained Earnings 8.72b / Total Assets 35.77b) |
| C: 0.15 (EBIT TTM 4.97b / Avg Total Assets 33.76b) |
| D: 0.40 (Book Value of Equity 10.19b / Total Liabilities 25.58b) |
| Altman-Z'' Score: 2.54 = A |
Beneish M
| DSRI: none (Receivables none/618.0m, Revenue 60.37b/56.36b) |
| GMI: 0.99 (GM 31.06% / 30.60%) |
| AQI: 1.01 (AQ_t 0.06 / AQ_t-1 0.06) |
| SGI: 1.07 (Revenue 60.37b / 56.36b) |
| TATA: -0.04 (NI 5.49b - CFO 6.81b) / TA 35.77b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of TJX shares?
As of March 02, 2026, the stock is trading at USD 161.66 with a total of 3,541,776 shares traded.
Over the past week, the price has changed by +2.52%, over one month by +7.96%, over three months by +7.27% and over the past year by +32.45%.
Over the past week, the price has changed by +2.52%, over one month by +7.96%, over three months by +7.27% and over the past year by +32.45%.
Is TJX a buy, sell or hold?
The TJX Companies has received a consensus analysts rating of 4.43.
Therefore, it is recommended to buy TJX.
- StrongBuy: 15
- Buy: 5
- Hold: 2
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the TJX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 171.3 | 6% |
| Analysts Target Price | 171.3 | 6% |
TJX Fundamental Data Overview February 28, 2026
P/E Trailing = 35.6865
P/E Forward = 30.581
P/S = 2.9802
P/B = 18.8289
P/EG = 3.2488
Revenue TTM = 60.37b USD
EBIT TTM = 4.97b USD
EBITDA TTM = 8.28b USD
Long Term Debt = 1.87b USD (from longTermDebt, two quarters ago)
Short Term Debt = 2.73b USD (from shortTermDebt, last quarter)
Debt = 22.38b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.15b USD (from netDebt column, last quarter)
Enterprise Value = 196.07b USD (179.92b + Debt 22.38b - CCE 6.23b)
Interest Coverage Ratio = 54.65 (Ebit TTM 4.97b / Interest Expense TTM 91.0m)
EV/FCF = 40.38x (Enterprise Value 196.07b / FCF TTM 4.86b)
FCF Yield = 2.48% (FCF TTM 4.86b / Enterprise Value 196.07b)
FCF Margin = 8.04% (FCF TTM 4.86b / Revenue TTM 60.37b)
Net Margin = 9.10% (Net Income TTM 5.49b / Revenue TTM 60.37b)
Gross Margin = 31.06% ((Revenue TTM 60.37b - Cost of Revenue TTM 41.62b) / Revenue TTM)
Gross Margin QoQ = 30.86% (prev 32.96%)
Tobins Q-Ratio = 5.48 (Enterprise Value 196.07b / Total Assets 35.77b)
Interest Expense / Debt = 0.16% (Interest Expense 36.0m / Debt 22.38b)
Taxrate = 25.82% (617.0m / 2.39b)
NOPAT = 3.69b (EBIT 4.97b * (1 - 25.82%))
Current Ratio = 1.14 (Total Current Assets 15.20b / Total Current Liabilities 13.36b)
Debt / Equity = 2.20 (Debt 22.38b / totalStockholderEquity, last quarter 10.19b)
Debt / EBITDA = 1.95 (Net Debt 16.15b / EBITDA 8.28b)
Debt / FCF = 3.33 (Net Debt 16.15b / FCF TTM 4.86b)
Total Stockholder Equity = 9.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.27% (Net Income 5.49b / Total Assets 35.77b)
RoE = 59.53% (Net Income TTM 5.49b / Total Stockholder Equity 9.23b)
RoCE = 44.80% (EBIT 4.97b / Capital Employed (Equity 9.23b + L.T.Debt 1.87b))
RoIC = 31.33% (NOPAT 3.69b / Invested Capital 11.78b)
WACC = 6.73% (E(179.92b)/V(202.30b) * Re(7.55%) + D(22.38b)/V(202.30b) * Rd(0.16%) * (1-Tc(0.26)))
Discount Rate = 7.55% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.70%
[DCF] Terminal Value 83.46% ; FCFF base≈4.59b ; Y1≈4.79b ; Y5≈5.51b
[DCF] Fair Price = 100.8 (EV 128.12b - Net Debt 16.15b = Equity 111.96b / Shares 1.11b; r=6.73% [WACC]; 5y FCF grow 4.51% → 2.90% )
EPS Correlation: 84.34 | EPS CAGR: 25.21% | SUE: 4.0 | # QB: 3
Revenue Correlation: 71.41 | Revenue CAGR: 12.50% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-04-30): EPS=1.00 | Chg7d=-0.019 | Chg30d=-0.022 | Revisions Net=-1 | Analysts=7
EPS current Year (2027-01-31): EPS=5.11 | Chg7d=-0.053 | Chg30d=-0.050 | Revisions Net=-1 | Growth EPS=+4.8% | Growth Revenue=+5.7%
EPS next Year (2028-01-31): EPS=5.66 | Chg7d=-0.077 | Chg30d=-0.068 | Revisions Net=-2 | Growth EPS=+10.8% | Growth Revenue=+5.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.1% (Discount Rate 7.9% - Earnings Yield 2.8%)
[Growth] Growth Spread = +1.4% (Analyst 6.5% - Implied 5.1%)
P/E Forward = 30.581
P/S = 2.9802
P/B = 18.8289
P/EG = 3.2488
Revenue TTM = 60.37b USD
EBIT TTM = 4.97b USD
EBITDA TTM = 8.28b USD
Long Term Debt = 1.87b USD (from longTermDebt, two quarters ago)
Short Term Debt = 2.73b USD (from shortTermDebt, last quarter)
Debt = 22.38b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.15b USD (from netDebt column, last quarter)
Enterprise Value = 196.07b USD (179.92b + Debt 22.38b - CCE 6.23b)
Interest Coverage Ratio = 54.65 (Ebit TTM 4.97b / Interest Expense TTM 91.0m)
EV/FCF = 40.38x (Enterprise Value 196.07b / FCF TTM 4.86b)
FCF Yield = 2.48% (FCF TTM 4.86b / Enterprise Value 196.07b)
FCF Margin = 8.04% (FCF TTM 4.86b / Revenue TTM 60.37b)
Net Margin = 9.10% (Net Income TTM 5.49b / Revenue TTM 60.37b)
Gross Margin = 31.06% ((Revenue TTM 60.37b - Cost of Revenue TTM 41.62b) / Revenue TTM)
Gross Margin QoQ = 30.86% (prev 32.96%)
Tobins Q-Ratio = 5.48 (Enterprise Value 196.07b / Total Assets 35.77b)
Interest Expense / Debt = 0.16% (Interest Expense 36.0m / Debt 22.38b)
Taxrate = 25.82% (617.0m / 2.39b)
NOPAT = 3.69b (EBIT 4.97b * (1 - 25.82%))
Current Ratio = 1.14 (Total Current Assets 15.20b / Total Current Liabilities 13.36b)
Debt / Equity = 2.20 (Debt 22.38b / totalStockholderEquity, last quarter 10.19b)
Debt / EBITDA = 1.95 (Net Debt 16.15b / EBITDA 8.28b)
Debt / FCF = 3.33 (Net Debt 16.15b / FCF TTM 4.86b)
Total Stockholder Equity = 9.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.27% (Net Income 5.49b / Total Assets 35.77b)
RoE = 59.53% (Net Income TTM 5.49b / Total Stockholder Equity 9.23b)
RoCE = 44.80% (EBIT 4.97b / Capital Employed (Equity 9.23b + L.T.Debt 1.87b))
RoIC = 31.33% (NOPAT 3.69b / Invested Capital 11.78b)
WACC = 6.73% (E(179.92b)/V(202.30b) * Re(7.55%) + D(22.38b)/V(202.30b) * Rd(0.16%) * (1-Tc(0.26)))
Discount Rate = 7.55% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.70%
[DCF] Terminal Value 83.46% ; FCFF base≈4.59b ; Y1≈4.79b ; Y5≈5.51b
[DCF] Fair Price = 100.8 (EV 128.12b - Net Debt 16.15b = Equity 111.96b / Shares 1.11b; r=6.73% [WACC]; 5y FCF grow 4.51% → 2.90% )
EPS Correlation: 84.34 | EPS CAGR: 25.21% | SUE: 4.0 | # QB: 3
Revenue Correlation: 71.41 | Revenue CAGR: 12.50% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-04-30): EPS=1.00 | Chg7d=-0.019 | Chg30d=-0.022 | Revisions Net=-1 | Analysts=7
EPS current Year (2027-01-31): EPS=5.11 | Chg7d=-0.053 | Chg30d=-0.050 | Revisions Net=-1 | Growth EPS=+4.8% | Growth Revenue=+5.7%
EPS next Year (2028-01-31): EPS=5.66 | Chg7d=-0.077 | Chg30d=-0.068 | Revisions Net=-2 | Growth EPS=+10.8% | Growth Revenue=+5.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.1% (Discount Rate 7.9% - Earnings Yield 2.8%)
[Growth] Growth Spread = +1.4% (Analyst 6.5% - Implied 5.1%)